Stem cell markers: insights from membrane proteomics?

Sung-Min AhnRichard J Simpson


Stem cells (SCs) are defined by their combined abilities to both self-renew indefinitely in vitro and differentiate into adult cell types. One of the major driving forces of SC research is that SCs may provide a potentially unlimited source for cell-replacement therapies in regenerative medicine. However, the identification of SCs and their progenies at different stages, and the success of cell-replacement therapies, which form the basis of SC engineering, will depend on the ability to characterize and ultimately isolate homogeneous primary stem or progenitor cell populations to a large degree. Furthermore, the recent identification of cancer stem cells (CSCs) opens a new avenue for developing novel therapeutic strategies by targeting a specific subset of cancer cells with self-renewal and proliferation capacity. Crucial to these tasks will be the discovery of novel plasma membrane-associated SC markers. In this review, we focus on the seminal contribution that membrane proteomics could make to further clinical applications of SCs by providing tools for purification and identification of SCs and their progenies at each stage of differentiation, as well as, to understand the underlying mechanisms of SC differentiation. The need ...Continue Reading


Jul 29, 1991·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·D Metcalf
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·D F HuntC R Hauer
Jan 1, 1994·Research in Immunology·G A BentleyV Chitarra
Mar 1, 1996·Trends in Neurosciences·C W OlanowT B Freeman
Apr 1, 1997·Molecular Biology of the Cell·R V StanG E Palade
May 6, 1998·Protein Science : a Publication of the Protein Society·E Wallin, G von Heijne
Nov 6, 1998·Science·J A ThomsonJ M Jones
Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·M J ShamblottJ D Gearhart
Nov 4, 2000·Nature Medicine·A Björklund, O Lindvall
Nov 2, 2001·Nature·T ReyaI L Weissman
Dec 26, 2001·Science's STKE : Signal Transduction Knowledge Environment·T Harder, M Kuhn
May 2, 2002·Cell·John J O'SheaRobert D Schreiber
Sep 5, 2002·Nature Reviews. Drug Discovery·Andrew L Hopkins, Colin R Groom
Oct 17, 2002·Proceedings of the National Academy of Sciences of the United States of America·Oleg N SuslovDennis A Steindler
Dec 21, 2002·The Journal of Biological Chemistry·Bong Kyung ShinSamir M Hanash
Mar 1, 2003·Nature Biotechnology·Christine C Wu, John R Yates
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Apr 2, 2003·Cell Biology Education·Bruce Alberts, UNKNOWN National Academies
Jun 11, 2003·Molecular & Cellular Proteomics : MCP·Charlotta AgatonMathias Uhlén
Jul 16, 2003·Trends in Immunology·Heddy Zola, Bernadette W Swart
Aug 21, 2003·Electrophoresis·Wei ZhangYingming Zhao
Aug 31, 1960·Annals of the New York Academy of Sciences·P EDMAN
Oct 24, 2003·Molecular & Cellular Proteomics : MCP·Matthew J PeirceAndrew P Cope
Jan 7, 2004·Nature Reviews. Drug Discovery·John McNeish
Jan 23, 2004·Nature Reviews. Cancer·Ricardo PardalSean J Morrison
Apr 1, 2004·Analytical Chemistry·Yingxin ZhaoYingming Zhao
Jun 23, 2004·Critical Reviews in Oncology/hematology·Stewart Sell
Aug 12, 2004·BMC Developmental Biology·Ralph BrandenbergerMahendra Rao
Sep 14, 2004·Journal of Proteome Research·Dhiman GhoshJohn A Wilkins
Oct 22, 2004·Nature·UNKNOWN International Human Genome Sequencing Consortium
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
Dec 15, 2004·Journal of Proteome Research·Amir M Rahbar, Catherine Fenselau
Feb 8, 2005·Molecular & Cellular Proteomics : MCP·Mathias Uhlen, Fredrik Ponten
Mar 15, 2005·FEBS Letters·Carolina Perez-IratxetaMiguel A Andrade

❮ Previous
Next ❯


Jun 5, 1998·Immunology Today·B ReizisI R Cohen
Jan 4, 2013·PloS One·Brian J MorrisonJ Alejandro Lopez
Mar 24, 2009·FEBS Letters·Miroslava StastnaJennifer E Van Eyk
Feb 19, 2011·Expert Review of Proteomics·Sonja ReilandJeroen Krijgsveld
Sep 1, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Hitoshi KitamuraHiroaki Shimoyamada
Mar 13, 2016·Cancer Letters·Alshaimaa AbdelmoezIra-Ida Skvortsova
Jul 28, 2011·Journal of Cellular Physiology·Andrew J K Williamson, Anthony D Whetton
Oct 18, 2011·Critical Reviews in Biochemistry and Molecular Biology·Justin BrumbaughJoshua J Coon
Aug 28, 2012·Biochimica Et Biophysica Acta·Isotta ChimentiAlessandro Giacomello
Apr 22, 2015·PloS One·Damaris Bausch-FluckBernd Wollscheid
Oct 30, 2016·Journal of Cellular Physiology·Jie LiJinlin Song

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.